Role of acetaldehyde in tobacco smoke addiction

European Neuropsychopharmacology

Volumn 17, Issue 10, 2007, Pages 627-636

  Talhout, Reinskje ^a   Opperhuizen, Antoon ^a   van Amsterdam, Jan G C ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Acetaldehyde; Addiction; Harman; Salsolinol; Smoke; Tobacco

Indexed keywords

ACETALDEHYDE; AMINE OXIDASE (FLAVIN CONTAINING); BIOGENIC AMINE; CIGARETTE SMOKE; HARMAN; MONOAMINE OXIDASE INHIBITOR; NICOTINE; SALSOLINOL; TOBACCO SMOKE;

ADDICTION; BLOOD BRAIN BARRIER; DRUG MECHANISM; DRUG SELF ADMINISTRATION; ENZYME INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; RODENT; TOBACCO DEPENDENCE;

ACETALDEHYDE; ANIMALS; BEHAVIOR, ANIMAL; HARMINE; HUMANS; SALSOLINE ALKALOIDS; TETRAHYDROISOQUINOLINES; TOBACCO USE DISORDER;

EID: 34547953132     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2007.02.013     Document Type: Review

References (108)

1. Action on Smoking and Health, 2005. Factsheet no. 2. Smoking statistics: illness and death. Available from: .
2. Adachi J., Mizoi Y., Fukunaga T., Kogame M., Ninomiya I., and Naito T. Effect of acetaldehyde on urinary salsolinol in healthy man after ethanol intake. Alcohol 3 (1986) 215-220
3. Adell A., and Myers R.D. Increased alcohol intake in low alcohol drinking rats after chronic infusion of the beta-carboline harman into the hippocampus. Pharmacol. Biochem. Behav. 49 (1994) 949-953
4. Adell A., Biggs T.A., and Myers R.D. Action of harman (1-methyl-beta-carboline) on the brain: body temperature and in vivo efflux of 5-HT from hippocampus of the rat. Neuropharmacol. 35 (1996) 1101-1107
5. Adriani W., Spijker S., Deroche-Gamonet V., Laviola G., Le Moal M., Smit A.B., and Piazza P.V. Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J. Neurosci. 23 (2003) 4712-4716
6. Airaksinen M.M., and Kari I. Beta-carbolines, psychoactive compounds in the mammalian body. Part I: occurrence, origin and metabolism. Med. Biol. 59 (1981) 21-34
7. Airaksinen M.M., and Kari I. Beta-carbolines, psychoactive compounds in the mammalian body. Part II: effects. Med. Biol. 59 (1981) 190-211
8. Amit Z., and Smith B.R. A multi-dimensional examination of the positive reinforcing properties of acetaldehyde. Alcohol 2 (1985) 367-370
9. Amit Z., Brown Z.W., and Rockman G.E. Possible involvement of acetaldehyde, norepinephrine and their tetrahydroisoquinoline derivatives in the regulation of ethanol self-administration. Drug Alcohol Depend. 2 (1977) 495-500fs
10. Annovazzi L., Cattaneo V., Viglio S., Perani E., Zanone C., Rota C., Pecora F., Cetta G., Silvestri M., and Iadarola P. High-performance liquid chromatography and capillary electrophoresis: methodological challenges for the determination of biologically relevant low-aliphatic aldehydes in human saliva. Electrophoresis 25 (2004) 1255-1263
11. Aricioglu F., and Altunbas H. Harmane induces anxiolysis and antidepressant-like effects in rats. Ann. N. Y. Acad. Sci. 1009 (2003) 196-201
12. Barrett S.P., Tichauer M., Leyton M., and Pihl R.O. Nicotine increases alcohol self-administration in non-dependent male smokers. Drug Alcohol Depend. 81 (2006) 197-204
13. Bates C., Jarvis M., and Connolly G. Tobacco Additives: Cigarette Engineering and Nicotine Addiction (1999). http://www.ash.org.uk/html/regulation/html/additives.html Available from:
14. Baum S.S., Hill R., and Rommelspacher H. Harman-induced changes of extracellular concentrations of neurotransmitters in the nucleus accumbens of rats. Eur. J. Pharmacol. 314 (1996) 75-82
15. Belluzzi J.D., Wang R., and Leslie F.M. Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacol. 30 (2005) 705-712
16. Berlin I., and Anthenelli R.M. Monoamine oxidases and tobacco smoking. Int. J. Neuropsychopharmacol. 4 (2001) 33-42
17. Boulton A.A., Yu P.H., and Tipton K.F. Biogenic amine adducts, monoamine oxidase inhibitors, and smoking. Lancet 1 (1988) 114-115
18. Breyer-Pfaff U., Wiatr G., Stevens I., Gaertner H.J., Mundle G., and Mann K. Elevated norharman plasma levels in alcoholic patients and controls resulting from tobacco smoking. Life Sci. 58 (1996) 1425-1432
19. Brody A.L. Functional brain imaging of tobacco use and dependence. J. Psychiatr. Res. 40 (2005) 404-418
20. Brown Z.W., Amit Z., and Rockman G.E. Intraventricular self-administration of acetaldehyde, but not ethanol, in naive laboratory rats. Psychopharmacol. (Berl) 64 (1979) 271-276
21. Charles J.L., Denoble V.J., and Mele P.C. Behavioral Pharmacology Annual Report - 1983 (1983). http://tobaccodocuments.org/pm/1003060364-0441.html Available from:
22. Collins M.A. Acetaldehyde and its condensation products as markers in alcoholism. Recent Dev. Alcohol 6 (1988) 387-403
23. Collins A.C., Cashaw J.L., and Davis V.E. Dopamine-derived tetrahydroisoquinoline alkaloids - inhibitors of neuroamine metabolism. Biochem. Pharmacol. 22 (1973) 2337-2348
24. Collins M.A., Nijm W.P., Borge G.F., Teas G., and Goldfarb C. Dopamine-related tetrahydroisoquinolines: significant urinary excretion by alcoholics after alcohol consumption. Science 206 (1979) 1184-1186
25. Collins M.A., Ung-Chhun N., Cheng B.Y., and Pronger D. Brain and plasma tetrahydroisoquinolines in rats: effects of chronic ethanol intake and diet. J. Neurochem. 55 (1990) 1507-1514
26. Dalhamn T., Edfors M.L., and Rylander R. Retention of cigarette smoke components in human lungs. Arch. Environ. Health 17 (1968) 746-748
27. Dar R., and Frenk H. Do smokers self-administer pure nicotine? A review of the evidence. Psychopharmacol. (Berl) 173 (2004) 18-26
28. Dar R., and Frenk H. Nicotine may reinforce intravenous drug-taking behavior in drug users: a comment on Harvey et al. (2004). Psychopharmacol. (Berl) 179 (2005) 516-517
29. Deitrich R.A. Acetaldehyde: deja vu du jour. J. Stud. Alcohol 65 (2004) 557-572
30. Deitrich R., and Erwin V. Biogenic amine-aldehyde condensation products: tetrahydroisoquinolines and tryptolines (beta-carbolines). Annu. Rev. Pharmacol. Toxicol. 20 (1980) 55-80
31. Duncan M.W., and Smythe G.A. Salsolinol and dopamine in alcoholic beverages. Lancet 1 (1982) 904-905
32. Ezzati M., and Lopez A.D. Estimates of global mortality attributable to smoking in 2000. The Lancet 362 (2003) 847-852
33. Faraj B.A., Camp V.M., Davis D.C., Lenton J.D., and Kutner M. Elevation of plasma salsolinol sulfate in chronic alcoholics as compared to nonalcoholics. Alcohol., Clin. Exp. Res. 13 (1989) 155-163
34. Farzin D., and Mansouri N. Antidepressant-like effect of harmane and other beta-carbolines in the mouse forced swim test. Eur. Neuropsychopharmacol. 16 (2006) 324-328
35. Fekkes D., Spijkermans R., van den Eijnden R., and Bongers I. The role of norharman in alcohol dependence and smoking: the potential inhibitory role of norharman on the urge for alcohol and nicotine use. J. Subs. Use 10 (2005) 106-118
36. Foddai M., Dosia G., Spiga S., and Diana M. Acetaldehyde increases dopaminergic neuronal activity in the VTA. Neuropsychopharmacol. 29 (2004) 530-536
37. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., Shea C., Alexoff D., MacGregor R.R., Schlyer D.J., Zezulkova I., and Wolf A.P. Brain monoamine oxidase A inhibition in cigarette smokers. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 14065-14069
38. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., MacGregor R., Alexoff D., Wolf A.P., Warner D., Cilento R., and Zezulkova I. Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. J. Addict. Dis. 17 (1998) 23-34
39. Fowler J.S., Logan J., Wang G.J., and Volkow N.D. Monoamine oxidase and cigarette smoking. Neurotoxicology 24 (2003) 75-82
40. Gamberino W.C., and Gold M.S. Neurobiology of tobacco smoking and other addictive disorders. Psychiatr. Clin. North Am. 22 (1999) 301-312
41. Giovine A., Renis M., and Bertolino A. In vivo and in vitro studies on the effect of tetrahydropapaveroline and salsolinol on COMT and MAO activity in rat brain. Pharmacol. 14 (1976) 86-94
42. Guillem K., Vouillac C., Cador M., Stinus L., Azar M.R., Parsons L.H., and Koob G.F. Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J. Neurosci. 25 (2005) 8593-8600
43. Harvey D.M., Yasar S., Heishman S.J., Panlilio L.V., Henningfield J.E., and Goldberg S.R. Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Psychopharmacol. (Berl) 175 (2004) 134-142
44. Herraiz T. Relative exposure to beta-carbolines norharman and harman from foods and tobacco smoke. Food Addit. Contam. 21 (2004) 1041-1050
45. Herraiz T., and Chaparro C. Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee. Life Sci. 78 (2005) 795-802
46. Herraiz T., and Chaparro C. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors. Biochem. Biophys. Res. Commun. 326 (2005) 378-386
47. Hirst M., Evans D.R., Gowdey C.W., and Adams M.A. The influences of ethanol and other factors on the excretion of urinary salsolinol in social drinkers. Pharmacol. Biochem. Behav. 22 (1985) 993-1000
48. Hobara N., Watanabe A., Kobayashi M., Nakatsukasa H., Nagashima H., Fukuda T., and Araki Y. Tissue distribution of acetaldehyde in rats following acetaldehyde inhalation and intragastric ethanol administration. Bull. Environ. Contam. Toxicol. 35 (1985) 393-396
49. Hoffmann D., and Hoffmann I. Letters to the editor, tobacco smoke components. Beitr. Tab.forsch. Int. 18 (1998) 49-52
50. Hoover D.J., and Brien J.F. Acetaldehyde concentration in rat blood and brain during the calcium carbimide-ethanol interaction. Can. J. Physiol. Pharm. 59 (1981) 65-70
51. Hunt W.A. Role of acetaldehyde in the actions of ethanol on the brain - a review. Alcohol 13 (1996) 147-151
52. Jamal M., Ameno K., Ameno S., Okada N., and Ijiri I. In vivo study of salsolinol produced by a high concentration of acetaldehyde in the striatum and nucleus accumbens of free-moving rats. Alcohol., Clin. Exp. Res. 27 (2003) 79S-84S
53. Jamal M., Ameno K., Kubota T., Ameno S., Zhang X., Kumihashi M., and Ijiri I. In vivo formation of salsolinol induced by high acetaldehyde concentration in rat striatum employing microdialysis. Alcohol Alcohol. 38 (2003) 197-201
54. Jauhonen P., Baraona E., Miyakawa H., and Lieber C.S. Origin of breath acetaldehyde during ethanol oxidation. Effect of long-term cigarette smoking. J. Lab. Clin. Med. 100 (1982) 908-916
55. Jones A.W. Measuring and reporting the concentration of acetaldehyde in human breath. Alcohol Alcohol. 30 (1995) 271-285
56. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13 (1992) 177-184
57. Kunin D., Latendresse M.W., Gaskin S., Smith B.R., and Amit Z. Preexposure effects of nicotine and acetaldehyde on conditioned taste aversion induced by both drugs. Pharmacol. Biochem. Behav. 66 (2000) 695-699
58. Lewis A., Miller J.H., and Lea R.A. Monoamine oxidase and tobacco dependence. Neurotoxicology 28 (2006) 182-195
59. Matsubara K., Akane A., Maseda C., Takahashi S., and Fukui Y. Salsolinol in the urine of nonalcoholic individuals after long-term moderate drinking. Alcohol Drug Res. 6 (1985) 281-288
60. Matsuzawa S., Suzuki T., and Misawa M. Involvement of mu-opioid receptor in the salsolinol-associated place preference in rats exposed to conditioned fear stress. Alcohol., Clin. Exp. Res. 24 (2000) 366-372
61. McBride W.J., Li T.K., Deitrich R.A., Zimatkin S., Smith B.R., and Rodd-Henricks Z.A. Involvement of acetaldehyde in alcohol addiction. Alcohol., Clin. Exp. Res. 26 (2002) 114-119
62. McLaughlin S.D., Scott B.K., and Peterson C.M. The effect of cigarette smoking on breath and whole blood-associated acetaldehyde. Alcohol 7 (1990) 285-287
63. Melzig M.F., and Zipper J. Effects of salsolinol on cultivated endothelial cells. Neurochem. Res. 18 (1993) 689-693
64. Melzig M.F., Putscher I., Henklein P., and Haber H. In vitro pharmacological activity of the tetrahydroisoquinoline salsolinol present in products from Theobroma cacao L. like cocoa and chocolate. J. Ethnopharmacol. 73 (2000) 153-159
65. Musshoff F., Lachenmeier D.W., Schmidt P., Dettmeyer R., and Madea B. Systematic regional study of dopamine, norsalsolinol, and (R/S)-salsolinol levels in human brain areas of alcoholics. Alcohol., Clin. Exp. Res. 29 (2005) 46-52
66. Myers R.D. Multiple metabolite theory, alcohol drinking and the alcogene. Prog. Clin. Biol. Res. 183 (1985) 201-220
67. Myers W.D., Ng K.T., and Singer G. Intravenous self-administration of acetaldehyde in the rat as a function of schedule, food deprivation and photoperiod. Pharmacol. Biochem. Behav. 17 (1982) 807-811
68. Myers W.D., Ng K.T., Singer G., Smythe G.A., and Duncan M.W. Dopamine and salsolinol levels in rat hypothalami and striatum after schedule-induced self-injection (SISI) of ethanol and acetaldehyde. Brain Res. 358 (1985) 122-128
69. Naoi M., Maruyama W., and Nagy G.M. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains. Neurotoxicology 25 (2004) 193-204
70. Nowak R. Was safer cigarette research snuffed?. Science 264 (1994) 766-767
71. Origitano T., Hannigan J., and Collins M.A. Rat brain salsolinol and blood-brain barrier. Brain Res. 224 (1981) 446-451
72. Paschke T., Scherer G., and Heller W.-H. Effects of ingredients on cigarette smoke composition and biological activity: a literature overview. Beitr. Tab.forsch. Int. 20 (2002) 107-247
73. Patsenka A., and Antkiewicz-Michaluk L. Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds - 1,2,3,4-tetrahydroisoquinoline alkaloids. Pol. J. Pharmacol. 56 (2004) 727-734
74. Perkins K.A. Response to Dar and Frenk (2004), "Do smokers self-administer pure nicotine? A review of the evidence". Psychopharmacol. (Berl) 175 (2004) 256-258
75. Pfau W., and Skog K. Exposure to beta-carbolines norharman and harman. J. Chromatogr. B, Analyt. Technol. Biomed. Life Sci. 802 (2004) 115-126
76. Poindexter E.H., and Carpenter R.D. The isolation of harmane and norharmane from tobacco and cigarette smoke. Phytochemistry 1 (1962) 215-221
77. Poso A.R., Hillbom M.E., and Eriksson L. Acetaldehyde penetrates the blood-liquor barrier of goats. Toxicol. Lett. 8 (1981) 57-62
78. Quertemont E. Genetic polymorphism in ethanol metabolism: acetaldehyde contribution to alcohol abuse and alcoholism. Mol. Psychiatry 9 (2004) 570-581
79. Quertemont E., and De Witte P. Conditioned stimulus preference after acetaldehyde but not ethanol injections. Pharmacol. Biochem. Behav. 68 (2001) 449-454
80. Quertemont E., and Tambour S. Is ethanol a pro-drug? The role of acetaldehyde in the central effects of ethanol. Trends Pharmacol. Sci. 25 (2004) 130-134
81. Quintanilla M.E., and Tampier L. Acetaldehyde-reinforcing effects: differences in low-alcohol-drinking (UChA) and high-alcohol-drinking (UChB) rats. Alcohol 31 (2003) 63-69
82. Riggin R.M., and Kissinger P.T. Letter: Identification of salsolinol as a phenolic component in powdered cocoa and cocoa-based products. J. Agric. Food Chem. 24 (1976) 900
83. Riggin R.M., McCarthy M.J., and Kissinger P.T. Identification of salsolinol as a major dopamine metabolite in the banana. J. Agric. Food Chem. 24 (1976) 189-191
84. Rodd Z.A., Bell R.L., Zhang Y., Goldstein A., Zaffaroni A., McBride W.J., and Li T.K. Salsolinol produces reinforcing effects in the nucleus accumbens shell of alcohol-preferring (P) rats. Alcohol., Clin. Exp. Res. 27 (2003) 440-449
85. Rodd-Henricks Z.A., Melendez R.I., Zaffaroni A., Goldstein A., McBride W.J., and Li T.K. The reinforcing effects of acetaldehyde in the posterior ventral tegmental area of alcohol-preferring rats. Pharmacol. Biochem. Behav. 72 (2002) 55-64
86. Rommelspacher H., Buchau C., and Weiss J. Harman induces preference for ethanol in rats: is the effect specific for ethanol?. Pharmacol. Biochem. Behav. 26 (1987) 749-755
87. Rommelspacher H., May T., and Salewski B. Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats. Eur. J. Pharmacol. 252 (1994) 51-59
88. Rommelspacher H., Meier-Henco M., Smolka M., and Kloft C. The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets. Eur. J. Pharmacol. 441 (2002) 115-125
89. Rose J.E. Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacol. (Berl) 184 (2006) 274-285
90. Rose J.E., Behm F.M., Ramsey C., and Ritchie J.C. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms. Nicotine Tob. Res. 3 (2001) 383-390
91. Seeman J.I., Dixon M., and Haussmann H.J. Acetaldehyde in mainstream tobacco smoke: formation and occurrence in smoke and bioavailability in the smoker. Chem. Res. Toxicol. 15 (2002) 1331-1350
92. Shaskan E.G., and Dolinsky Z.S. Elevated endogenous breath acetaldehyde levels among abusers of alcohol and cigarettes. Prog. Neuro-psychopharmacol. Biol. Psychiatry 9 (1985) 267-272
93. Sippel H.W. The acetaldehyde content in rat brain during ethanol metabolism. J. Neurochem. 23 (1974) 451-452
94. Sjoquist B., and Magnuson E. Analysis of salsolinol and salsoline in biological samples using deuterium-labelled internal standards and gas chromatography-mass spectrometry. J. Chromatogr. 183 (1980) 17-24
95. Sjoquist B., Johnson H.A., and Borg S. The influence of acute ethanol on the catecholamine system in man as reflected in cerebrospinal fluid and urine. A new condensation product, 1-carboxysalsolinol. Drug Alcohol Depend. 16 (1985) 241-249
96. Smith B.R., Amit Z., and Splawinsky J. Conditioned place preference induced by intraventricular infusions of acetaldehyde. Alcohol 1 (1984) 193-195
97. Smith B.R., Horan J.T., Gaskin S., and Amit Z. Exposure to nicotine enhances acquisition of ethanol drinking by laboratory rats in a limited access paradigm. Psychopharmacol. (Berl) 142 (1999) 408-412
98. Smith C.J., Qian X., Zha Q., and Moldoveanu S.C. Analysis of alpha- and beta-carbolines in mainstream smoke of reference cigarettes by gas chromatography-mass spectrometry. J. Chromatogr. A 1046 (2004) 211-216
99. Soderpalm B., Ericson M., Olausson P., Blomqvist O., and Engel J.A. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav. Brain Res. 113 (2000) 85-96
100. Songstad D.D., De Luca V., Brisson N., Kurz W.G.W., and Nessler C.L. High levels of tryptamine accumulation in transgenic tobacco expressing tryptophan decarboxylase. Plant Physiol. 94 (1990) 1410-1413
101. Totsuka Y., Ushiyama H., Ishihara J., Sinha R., Goto S., Sugimura T., and Wakabayashi K. Quantification of the co-mutagenic beta-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods. Cancer Lett. 143 (1999) 139-143
102. Villegier A.S., Blanc G., Glowinski J., and Tassin J.P. Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors. Pharmacol. Biochem. Behav. 76 (2003) 267-274
103. Von Wartburg J.P. Acute aldehyde syndrome and chronic aldehydism. Mutat. Res. 186 (1987) 249-259
104. Weiner C.D., and Collins M.A. Tetrahydroisoquinolines derived from catecholamines or DOPA: effects on brain tyrosine hydroxylase activity. Biochem. Pharmacol. 27 (1978) 2699-2703
105. Westcott J.Y., Weiner H., Shultz J., and Myers R.D. In vivo acetaldehyde in the brain of the rat treated with ethanol. Biochem. Pharmacol. 29 (1980) 411-417
106. Willemsen M.C., Wagena E.J., and van Schayck C.P. The efficacy of smoking cessation methods available in the Netherlands: a systematic review based on Cochrane data. Ned. Tijdschr. Geneeskd. 147 (2003) 922-927
107. Wodarz N., Wiesbeck G.A., Rommelspacher H., Riederer P., and Boning J. Excretion of beta-carbolines harman and norharman in 24-hour urine of chronic alcoholics during withdrawal and controlled abstinence. Alcohol., Clin. Exp. Res. 20 (1996) 706-710
108. Zimatkin S.M., and Deitrich R.A. Ethanol metabolism in the brain. Addict. Biol. 2 (1997) 387-399